Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Pre-hospital treatment on the way to percutaneous coronary intervention

Pre-hospital treatment on the way to percutaneous coronary intervention

Safety of antithrombotic treatment in acute coronary syndromes

Safety of antithrombotic treatment in acute coronary syndromes

Factor Xa inhibitor Apixaban and antiplatelet therapy after acute coronary syndrome

Factor Xa inhibitor Apixaban and antiplatelet therapy after acute coronary syndrome

Overcoming poor response to standard oral antiplatelet agents

Overcoming poor response to standard oral antiplatelet agents

Two Penn studies show drug-eluting stents outperform bare metal stents

Two Penn studies show drug-eluting stents outperform bare metal stents

Reducing blockage fails to improve access to the bloodstream for kidney dialysis

Reducing blockage fails to improve access to the bloodstream for kidney dialysis

Study results on novel drug-eluting stent coated with a biodegradable polymer

Study results on novel drug-eluting stent coated with a biodegradable polymer

Matrix registry probes adherence to clopidogrel at 1 year

Matrix registry probes adherence to clopidogrel at 1 year

Patients at risk of adverse events within 3 months after stopping certain ACS therapy

Patients at risk of adverse events within 3 months after stopping certain ACS therapy

Half of patients undergoing cerebrovascular stent placement do not respond well to clopidogrel

Half of patients undergoing cerebrovascular stent placement do not respond well to clopidogrel

Aspirin resistance and heart attack - stroke risk

Aspirin resistance and heart attack - stroke risk

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.

The goals of platelet inhibition in acute coronary syndromes

The goals of platelet inhibition in acute coronary syndromes

How to optimally prepare a patient for planned coronary angiography and subsequent angioplasty?

How to optimally prepare a patient for planned coronary angiography and subsequent angioplasty?

Long-term treatment with anti-clotting drug clopidogrel improves stenting outcomes in diabetic patients

Long-term treatment with anti-clotting drug clopidogrel improves stenting outcomes in diabetic patients

High-dose clopidogrel before stenting cuts heart attack risk in half

High-dose clopidogrel before stenting cuts heart attack risk in half

Bare metal stents provide a safer choice

Bare metal stents provide a safer choice

Stent thrombosis

Stent thrombosis

Efforts to standardize heart care are working

Efforts to standardize heart care are working

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Schering-Plough plans phase III trials for novel selective antiplatelet therapy